CMS Reconsiders Role In Covering Recall-Related Patient Monitoring Costs
This article was originally published in The Gray Sheet
Executive Summary
CMS is weighing options to shift more of the cost of medical check-ups that result from product recalls from Medicare to manufacturers
You may also be interested in...
Patients Deserve More Information On Potentially Faulty Devices – Maisel
A leading expert on medical device safety wants Congress to compel FDA and manufacturers to provide more consumer protections for patients with implanted devices
Patients Deserve More Information On Potentially Faulty Devices – Maisel
A leading expert on medical device safety wants Congress to compel FDA and manufacturers to provide more consumer protections for patients with implanted devices
Physician Fee Schedule In Brief
Payments for recalled devices: Medicare costs may be "substantial and burdensome" when physicians have to monitor patients with recalled devices, CMS says in the 2008 physician fee schedule 1proposal. The agency is asking for stakeholder input on how to identify these additional Medicare expenditures. It cites Boston Scientific's April recall of implantable defibrillators with potentially defective batteries as an example of a recall that entails added office visit and diagnostic test expenses. CMS is "exploring what actions would be appropriate in the case of these additional monitoring and related expenses as they relate to both the hospital outpatient and physician payment systems" (2"The Gray Sheet" May 28, 2007, p. 13)...